Cubist Systematic Strategies’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.52M | Sell |
|
|||||
|
2024
Q3 | $8.34M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $3.92M | Buy |
|
|||||
|
2023
Q4 | $1.28M | Sell |
|
|||||
|
2023
Q3 | $4.05M | Buy |
|
|||||
|
2023
Q2 | $605K | Sell |
|
|||||
|
2023
Q1 | $3.09M | Sell |
|
|||||
|
2022
Q4 | $7.13M | Buy |
|
|||||
|
2022
Q3 | $1.39M | Buy |
|
|||||
|
2022
Q2 | $581K | Sell |
|
|||||
|
2022
Q1 | $830K | Sell |
|
|||||
|
2021
Q4 | $3.77M | Buy |
|
|||||
|
2021
Q3 | $3.2M | Buy |
|
|||||
|
2021
Q2 | $2.79M | Buy |
|
|||||
|
2021
Q1 | $1.63M | Sell |
|
|||||
|
2020
Q4 | $2.23M | Sell |
|
|||||
|
2020
Q3 | $3.57M | Buy |
|
|||||
|
2020
Q2 | $2.77M | Buy |
|
|||||
|
2020
Q1 | $1.17M | Sell |
|
|||||
|
2019
Q4 | $2.67M | Buy |
|
|||||
|
2019
Q3 | $1.48M | Sell |
|
|||||
|
2019
Q2 | $2.45M | Buy |
|
|||||
|
2019
Q1 | $1.8M | Buy |
|
|||||
|
2018
Q4 | $720K | Buy |
|
|||||
|
2018
Q3 | $147K | Sell |
|
|||||
|
2018
Q2 | $214K | Buy |
|
|||||
|
2018
Q1 | $10K | Sell |
|
|||||
|
2017
Q4 | $211K | Buy |
|
|||||
|
2017
Q3 | $94K | Sell |
|
|||||
|
2017
Q2 | $152K | Buy |
|
|||||
|
2017
Q1 | $66K | Sell |
|
|||||
|
2016
Q4 | $208K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $134K | Sell |
|
|||||
|
2016
Q1 | $305K | Sell |
|
|||||
|
2015
Q4 | $837K | Sell |
|
|||||
|
2015
Q3 | $888K | Buy |
|
|||||
|
2015
Q2 | $265K | Sell |
|
|||||
|
2015
Q1 | $853K | Buy |
|
|||||
|
2014
Q4 | $337K | Buy |
|
|||||
|
2014
Q3 | $81K | Sell |
|
|||||
|
2014
Q2 | $138K | Buy |
|